Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

NCT01649635 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: CABAZITAXEL (XRP6258)
DRUG: Prednisone
DRUG: Ciprofloxacin
DRUG: G-CSF (Granulocyte colony-stimulating factor)

Sponsor

Sanofi